Browse by Research Team

2009

Randomized, double-blind, multicenter study of the endeavor zotarolimus-eluting phosphorylcholine-encapsulated stent for treatment of native coronary artery lesions.
Bergmann, M.W.
Herz 34 (6): 491. September 2009

2008

β-catenin downregulation attenuates ischemic cardiac remodeling through enhanced resident precursor cell differentiation.
Zelarayan, L.C. and Noack, C. and Sekkali, B. and Kmecova, J. and Gehrke, C. and Renger, A. and Zafiriou, M.P. and van der Nagel, R. and Dietz, R. and de Windt, L.J. and Balligand, J.L. and Bergmann, M.W.
Proceedings of the National Academy of Sciences of the United States of America 105 (50): 19762-19767. 16 December 2008

Treatment-sensitive premature renal and heart senescence in hypertension.
Bergmann, M.W. and Zelarayan, L.C. and Gehrke, C.
Hypertension 52 (1): 61-62. July 2008

2007

Role of beta-catenin in adult cardiac remodeling.
Zelarayan, L. and Gehrke, C. and Bergmann, M.W.
Cell Cycle 6 (17): 2120-2126. 1 September 2007

Enhancing repair of the mammalian heart.
Santini, M.P. and Tsao, L. and Monassier, L. and Theodoropoulos, C. and Carter, J. and Lara-Pezzi, E. and Slonimsky, E. and Salimova, E. and Delafontain, P. and Song, Y.H. and Bergmann, M. and Freund, C. and Suzuki, K. and Rosenthal, N.
Circulation Research 100 (12): 1732-1740. 22 June 2007

Linking cardiac mechanosensing at the sarcomere M-band, nuclear factor kappaB signaling, and cardiac remodeling.
Bergmann, M.W. and de Windt, L.J.
Hypertension 49 (6): 1225-1227. June 2007

Beta-catenin downregulation is required for adaptive cardiac remodeling.
Baurand, A. and Zelarayan, L. and Betney, R. and Gehrke, C. and Dunger, S. and Noack, C. and Busjahn, A. and Huelsken, J. and Taketo, M.M. and Birchmeier, W. and Dietz, R. and Bergmann, M.W.
Circulation Research 100 (9): 1353-1362. 11 May 2007

2005

Requirement of nuclear factor-kappaB in angiotensin II- and isoproterenol-induced cardiac hypertrophy in vivo.
Freund, C. and Schmidt-Ullrich, R. and Baurand, A. and Dunger, S. and Schneider, W. and Loser, P. and El-Jamali, A. and Dietz, R. and Scheidereit, C. and Bergmann, M.W.
Circulation 111 (18): 2319-2325. 1 January 2005

2004

Inhibitors of protein kinase C (PKC) prevent activated transcription - role of events downstream of NF-κB DNA binding.
Catley, M.C. and Cambridge, L.M. and Nasuhara, Y. and Ito, K. and Chivers, J.E. and Beaton, A. and Holden, N.S. and Bergmann, M.W. and Barnes, P.J. and Newton, R.
Journal of Biological Chemistry 279 (18): 18457-18466. 30 April 2004

Reoxygenation after severe hypoxia induces cardiomyocyte hypertrophy in vitro: activation of CREB downstream of GSK3beta.
El Jamali, A. and Freund, C. and Rechner, C. and Scheidereit, C. and Dietz, R. and Bergmann, M.W.
FASEB Journal 18 (10): 1096-1098. 1 January 2004

Statins inhibit reoxygenation-induced cardiomyocyte apoptosis: role for glycogen synthase kinase 3beta and transcription factor beta-catenin.
Bergmann, M.W. and Rechner, C. and Freund, C. and Baurand, A. and El Jamali, A. and Dietz, R.
Journal of Molecular and Cellular Cardiology 37 (3): 681-690. 1 January 2004

2003

IL-1 β-dependent activation of NF-κB mediates PGE(2)release via the expression of cyclooxygenase-2 and microsomal prostaglandin E synthase.
Catley, M.C. and Chivers, J.E. and Cambridge, L.M. and Holden, N. and Slater, D.M. and Staples, K.J. and Bergmann, M.W. and Loser, P. and Barnes, P.J. and Newton, R.
FEBS Letters 547 (1-3): 75-79. 17 July 2003

2001

Effect of NF-kappa B inhibition on TNF-alpha-induced apoptosis and downstream pathways in cardiomyocytes.
Bergmann, M.W. and Loeser, P. and Dietz, R. and von Harsdorf, R.
Journal of Molecular and Cellular Cardiology 33 : 1223-1232. 1 January 2001

GM-CSF expression in pulmonary epithelial cells is regulated negatively by posttranscriptional mechanisms.
Newton, R. and Staples, K.J. and Hart, L. and Barnes, P.J. and Bergmann, M.W.
Biochemical and Biophysical Research Communications 287 : 249-253. 1 January 2001

In cardiomyocyte hypoxia, insulin-like growth factor-I-induced antiapoptotic signaling requires phosphatidylinositol-3-OH-kinase-dependent and mitogen-activated protein kinase-dependent activation of the transcription factor cAMP response element-binding protein.
Mehrhof, F.B. and Mueller, F.U. and Bergmann, M.W. and Li, P.F. and Wang, Y.B. and Schmitz, W. and Dietz, R. and von Harsdorf, R.
Circulation 104 : 2088-2094. 1 January 2001